CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $20.70 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-05
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-27 was $12.40M, a 82.35% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-28 was $8.30M, a 167.74% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-12-27 was $200.00K, a 100.00% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-27 was $0.00, a 100.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $10.10M, a 45.41% decline from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $18.50M, a 23.55% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $24.20M, a 37.47% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $38.70M, a 4.91% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2026-06-27 | $12.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $20.70M 10-Q · filed 2026-08-05 | $20.90M derived: sum of 3 quarters · filed 2026-08-05 | $20.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | $8.30M 10-Q · filed 2026-05-07 | $8.50M derived: sum of 2 quarters · filed 2026-05-07 | $8.50M derived: sum of 3 quarters · filed 2026-05-07 | $15.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-27 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $200.00K derived: sum of 2 quarters · filed 2026-02-18 | $7.00M derived: sum of 3 quarters · filed 2026-08-05 | $10.10M 10-K · filed 2026-02-18 |
| 2025-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.80M derived: sum of 2 quarters · filed 2026-08-05 | $9.90M 10-Q · filed 2025-11-05 | $10.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-28 | $6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $9.90M 10-Q · filed 2026-08-05 | $10.00M derived: sum of 3 quarters · filed 2026-08-05 | $10.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-29 | $3.10M 10-Q · filed 2026-05-07 | $3.20M derived: sum of 2 quarters · filed 2026-05-07 | $3.30M derived: sum of 3 quarters · filed 2026-05-07 | $12.20M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-28 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $200.00K derived: sum of 2 quarters · filed 2026-02-18 | $9.10M derived: sum of 3 quarters · filed 2026-02-18 | $18.50M 10-K · filed 2026-02-18 |
| 2024-09-28 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $9.00M derived: sum of 2 quarters · filed 2025-11-05 | $18.40M 10-Q · filed 2025-11-05 | $18.60M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-29 | $8.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $18.30M 10-Q · filed 2025-08-06 | $18.50M derived: sum of 3 quarters · filed 2025-08-06 | $18.50M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-30 | $9.40M 10-Q · filed 2025-05-07 | $9.60M derived: sum of 2 quarters · filed 2025-05-07 | $9.60M derived: sum of 3 quarters · filed 2025-05-07 | $14.60M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-30 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $200.00K derived: sum of 2 quarters · filed 2025-02-19 | $5.20M derived: sum of 3 quarters · filed 2025-02-19 | $24.20M 10-K · filed 2025-02-19 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $5.00M derived: sum of 2 quarters · filed 2024-11-06 | $24.00M 10-Q · filed 2024-11-06 | $24.20M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-07-01 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $24.00M 10-Q · filed 2024-08-07 | $24.20M derived: sum of 3 quarters · filed 2024-08-07 | $24.20M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-04-01 | $19.00M 10-Q · filed 2024-05-09 | $19.20M derived: sum of 2 quarters · filed 2024-05-09 | $19.20M derived: sum of 3 quarters · filed 2024-05-09 | $23.70M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $200.00K derived: sum of 2 quarters · filed 2024-02-14 | $4.70M derived: sum of 3 quarters · filed 2024-02-14 | $38.70M 10-K · filed 2024-02-14 |
| 2022-09-24 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $4.50M derived: sum of 2 quarters · filed 2023-11-08 | $38.50M 10-Q · filed 2023-11-08 | $38.80M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-25 | $4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $38.50M 10-Q · filed 2023-08-09 | $38.80M derived: sum of 3 quarters · filed 2023-08-09 | $38.90M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-26 | $34.00M 10-Q · filed 2023-05-11 | $34.30M derived: sum of 2 quarters · filed 2023-05-11 | $34.40M derived: sum of 3 quarters · filed 2023-05-11 | $38.70M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-25 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $400.00K derived: sum of 2 quarters · filed 2023-02-22 | $4.70M derived: sum of 3 quarters · filed 2023-02-22 | $40.70M 10-K · filed 2023-02-22 |
| 2021-09-25 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $4.40M derived: sum of 2 quarters · filed 2022-11-02 | $40.40M 10-Q · filed 2022-11-02 | $40.50M derived: sum of 4 quarters · filed 2022-11-02 |
| 2021-06-26 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $40.30M 10-Q · filed 2022-08-03 | $40.40M derived: sum of 3 quarters · filed 2022-08-03 | $40.50M derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-27 | $36.00M 10-Q · filed 2022-05-04 | $36.10M derived: sum of 2 quarters · filed 2022-05-04 | $36.20M derived: sum of 3 quarters · filed 2022-05-04 | $36.30M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-26 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $200.00K derived: sum of 2 quarters · filed 2022-02-16 | $300.00K derived: sum of 3 quarters · filed 2022-02-16 | $24.00M 10-K · filed 2022-02-16 |
| 2020-09-26 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $200.00K derived: sum of 2 quarters · filed 2021-11-03 | $23.90M 10-Q · filed 2021-11-03 | $24.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-27 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $23.80M 10-Q · filed 2021-08-04 | $23.90M derived: sum of 3 quarters · filed 2022-02-16 | $24.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-28 | $23.70M 10-Q · filed 2021-05-04 | $23.80M derived: sum of 2 quarters · filed 2022-02-16 | $23.90M derived: sum of 3 quarters · filed 2022-02-16 | $24.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-28 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $200.00K derived: sum of 2 quarters · filed 2022-02-16 | $300.00K derived: sum of 3 quarters · filed 2022-02-16 | $18.10M 10-K · filed 2022-02-16 |
| 2019-09-28 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $200.00K derived: sum of 2 quarters · filed 2020-10-29 | $18.00M 10-Q · filed 2020-10-29 | $18.00M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-29 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $17.90M 10-Q · filed 2020-08-05 | $17.90M derived: sum of 3 quarters · filed 2021-02-17 | $18.00M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-30 | $17.80M 10-Q · filed 2020-05-07 | $17.80M derived: sum of 2 quarters · filed 2021-02-17 | $17.90M derived: sum of 3 quarters · filed 2021-02-17 | $18.10M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $100.00K derived: sum of 2 quarters · filed 2021-02-17 | $300.00K derived: sum of 3 quarters · filed 2021-02-17 | $13.80M 10-K · filed 2021-02-17 |
| 2018-09-29 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $300.00K derived: sum of 2 quarters · filed 2019-11-06 | $13.80M 10-Q · filed 2019-11-06 | $13.80M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $13.70M 10-Q · filed 2019-07-31 | $13.70M derived: sum of 3 quarters · filed 2020-02-11 | $13.70M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-03-31 | $13.50M 10-Q · filed 2019-05-07 | $13.50M derived: sum of 2 quarters · filed 2020-02-11 | $13.50M derived: sum of 3 quarters · filed 2020-02-11 | $13.70M derived: sum of 4 quarters · filed 2020-02-11 |
| 2017-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | $0.00 derived: sum of 2 quarters · filed 2020-02-11 | $200.00K derived: sum of 3 quarters · filed 2020-02-11 | $16.30M 10-K · filed 2020-02-11 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $200.00K derived: sum of 2 quarters · filed 2018-11-07 | $16.30M 10-Q · filed 2018-11-07 | $16.40M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-07-01 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $16.30M 10-Q · filed 2018-08-08 | $16.40M derived: sum of 3 quarters · filed 2019-02-13 | $16.40M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-04-01 | $16.10M 10-Q · filed 2018-05-10 | $16.20M derived: sum of 2 quarters · filed 2019-02-13 | $16.20M derived: sum of 3 quarters · filed 2019-02-13 | $16.30M derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $100.00K derived: sum of 2 quarters · filed 2019-02-13 | $200.00K derived: sum of 3 quarters · filed 2019-02-13 | $12.30M 10-K · filed 2019-02-13 |
| 2016-09-24 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $100.00K derived: sum of 2 quarters · filed 2017-11-09 | $12.20M 10-Q · filed 2017-11-09 | $12.20M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-25 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $12.20M 10-Q · filed 2017-08-09 | $12.20M derived: sum of 3 quarters · filed 2018-02-13 | $12.20M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-26 | $12.10M 10-Q · filed 2017-05-10 | $12.10M derived: sum of 2 quarters · filed 2018-02-13 | $12.10M derived: sum of 3 quarters · filed 2018-02-13 | |
| 2015-12-26 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $0.00 derived: sum of 2 quarters · filed 2018-02-13 | $8.70M 10-K · filed 2018-02-13 | |
| 2015-09-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $8.70M 10-Q · filed 2016-11-02 | ||
| 2015-06-27 | $8.70M 10-Q · filed 2016-08-03 | |||
| 2014-12-27 | $6.80M 10-K · filed 2017-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |